全文获取类型
收费全文 | 10950篇 |
免费 | 1100篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 74篇 |
儿科学 | 344篇 |
妇产科学 | 141篇 |
基础医学 | 1525篇 |
口腔科学 | 191篇 |
临床医学 | 2325篇 |
内科学 | 1167篇 |
皮肤病学 | 40篇 |
神经病学 | 761篇 |
特种医学 | 243篇 |
外国民族医学 | 1篇 |
外科学 | 528篇 |
综合类 | 985篇 |
一般理论 | 8篇 |
预防医学 | 2290篇 |
眼科学 | 58篇 |
药学 | 562篇 |
43篇 | |
中国医学 | 180篇 |
肿瘤学 | 685篇 |
出版年
2024年 | 11篇 |
2023年 | 228篇 |
2022年 | 345篇 |
2021年 | 555篇 |
2020年 | 615篇 |
2019年 | 586篇 |
2018年 | 579篇 |
2017年 | 542篇 |
2016年 | 450篇 |
2015年 | 442篇 |
2014年 | 790篇 |
2013年 | 1147篇 |
2012年 | 612篇 |
2011年 | 638篇 |
2010年 | 526篇 |
2009年 | 533篇 |
2008年 | 515篇 |
2007年 | 472篇 |
2006年 | 402篇 |
2005年 | 366篇 |
2004年 | 282篇 |
2003年 | 240篇 |
2002年 | 215篇 |
2001年 | 169篇 |
2000年 | 144篇 |
1999年 | 115篇 |
1998年 | 101篇 |
1997年 | 87篇 |
1996年 | 51篇 |
1995年 | 55篇 |
1994年 | 48篇 |
1993年 | 72篇 |
1992年 | 29篇 |
1991年 | 35篇 |
1990年 | 19篇 |
1989年 | 15篇 |
1988年 | 19篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 15篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1971年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
【目的】 在媒体融合的背景下,探索高校科技期刊获得良性、可持续发展的业务流程再造方案。【方法】 通过问卷调查法和深度访谈法,对《中国有色金属学报》学术用户的实际需求进行诊断分析,并依据《中国有色金属学报》一年内的业务流程再造实践,总结和设计普适性较强的高校科技期刊业务流程再造方案。【结果】 《中国有色金属学报》在学术用户群体服务与管理、学术资源挖掘和利用、缩短出版周期和媒体融合等方面进行业务流程再造并取得了显著成效。【结论】 高校科技期刊要想谋求新的发展和突破,必须基于用户日益增长的学术需求进行业务拓展,同时基于技术和机制,与时俱进地进行业务流程再造。 相似文献
3.
4.
《Value in health》2022,25(9):1480-1488
ObjectivesInvolvement of patients and medical professionals in assessment of relative effectiveness (relative effectiveness assessment) contributes to an efficient and effective health technology assessment (HTA) process and supports acceptance and implementation of the outcome. This study aimed to analyze stakeholder involvement in assessing relative effectiveness and how the parties involved value this collaboration.MethodsThis is a document analysis of all drug assessments completed in 2019 (20) by the public HTA agency of The Netherlands, enriched with semistructured interviews with employees of the HTA agency (18) and representatives of patient (5) and medical (11) associations involved in these assessments. Data were analyzed, coded, and categorized.ResultsIn almost half of the assessments, there was no coordination with the medical associations at the start of the relative effectiveness assessment and no patient associations involved in this phase. During the assessment procedure, patient and medical associations were always asked to comment on the draft report. Nevertheless, the strict 5-day deadline that the HTA agency uses as a response period often hampered a proper response and involvement. According to interviewees of the HTA agency, this leads to a great diversity in the substantive quality of their input. Patient and medical associations indicated that the HTA agency relies too much on “paper knowledge,” which leads to a (perceived) lack of alignment with clinical practice.ConclusionsThe limited involvement results in a lack of coordination and mutual trust. Optimizing involvement of patients and medical professionals in HTA practice requires effort from all parties involved. Procedural adjustments and better coordination, especially at the start of the assessment, would probably improve cooperation. 相似文献
5.
6.
7.
《The Medical clinics of North America》2022,106(4):705-714
8.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
9.
目的观察"管氏培元九宫"针法治疗功能性阳痿的临床疗效。方法将60例功能性阳痿患者按随机数字表法随机分为治疗组和对照组,每组30例。治疗组采用"管氏培元九宫"穴,按"洛书九宫数"施行针刺治疗;对照组口服复方玄驹胶囊。观察两组治疗前后国际勃起功能指数-5(IIEF-5)评分,并比较临床疗效。结果治疗组总有效率为80.0%,对照组为70.0%,两组比较差异具有统计学意义(P<0.05)。治疗组治疗后IIEF-5评分高于治疗前和对照组(P<0.05)。结论"管氏培元九宫"针法对功能性阳痿具有较好临床疗效。 相似文献
10.
This study investigated how doctors communicate the uncertainties of survival prognoses to patients recently diagnosed with life‐threatening cancer, and suggests ways to improve this communication. Two hundred thirty‐eight Norwegian oncologists and general practitioners (GPs) participated in Study 1. The study included both a scenario and a survey. The scenario asked participants to respond to a hypothetical patient who wanted to know how long (s)he could be expected to live. There were marked differences in responses within both groups, but few differences between the GPs and oncologists. There was a strong reluctance among doctors to provide patients with a prognosis. Even when they were presented with a statistically well‐founded right‐skewed survival curve, only a small minority provided hope by communicating the variation in survival time. In Study 2, 177 healthy students rated their preferences for different ways of receiving information regarding the uncertainty of a survival prognosis. Participants who received an explicitly described right‐skewed survival curve believed that they would feel more hopeful. These participants also obtained a more realistic understanding of the variation in survival than those who did not receive this information. Based on the findings of the two studies and on extant psychological research, the author suggests much‐needed guidelines for communicating survival prognoses in a realistic and optimistic way to patients recently diagnosed with life‐threatening cancer. In particular, the guidelines emphasise that the doctor explains the often strongly right‐skewed variation in survival time, and thereby providing the patient with realistic hope. 相似文献